# Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

> **NCT06853145** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Virginia** · enrollment: 6 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Hyperpolarized Xe129

## Key facts

- **NCT ID:** NCT06853145
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853145, "Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06853145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*